Facing the Reality of Drug-Resistant Tuberculosis in India
eBook - ePub

Facing the Reality of Drug-Resistant Tuberculosis in India

Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research

,
  1. English
  2. ePUB (mobile friendly)
  3. Available on iOS & Android
eBook - ePub

Facing the Reality of Drug-Resistant Tuberculosis in India

Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research

,

About this book

An estimated 8.8 million people fell ill with tuberculosis (TB) in 2010 and 1.4 million died from the disease. Although antibiotics to treat TB were developed in the 1950s and are effective against a majority of TB cases, resistance to these antibiotics has emerged over the years, resulting in the growing spread of multidrug-resistant (MDR) TB. Due to challenges in timely and accurate diagnosis of drug-resistant TB, length and tolerability of treatment regimens, and expense of second-line anti-TB drugs, effectively controlling the disease requires complex public health interventions.The IOM Forum on Drug Discovery, Development, and Translation held three international workshops to gather information from local experts around the world on the threat of drug resistant TB and how the challenges it presents can be met. Workshops were held in South Africa and Russia in 2010. The third workshop was held April 18-19, 2011, in New Delhi, India, in collaboration with the Indian National Science Academy and the Indian Council of Medical Research. The aim of the workshop was to highlight key challenges to controlling the spread of drug-resistant strains of TB in India and to discuss strategies for advancing and integrating local and international efforts to prevent and treat drug-resistant TB. This document summarizes the workshop.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Facing the Reality of Drug-Resistant Tuberculosis in India by in PDF and/or ePUB format. We have over one million books available in our catalogue for you to explore.

Information

Edition
0

Table of contents

  1. COVER PAGE
  2. TITLE PAGE
  3. COPYRIGHT PAGE
  4. TABLE OF CONTENTS
  5. ACRONYMS
  6. 1 INTRODUCTION
  7. 2 DRUG-RESISTANT TB IN INDIA
  8. 3 THE GLOBAL BURDEN OF DRUG-RESISTANT TB
  9. 4 PREVENTING TRANSMISSION OF DRUG-RESISTANT TB
  10. 5 DETECTING DRUG RESISTANCE AND STRENGTHENING LABORATORY CAPACITY
  11. 6 ADDRESSING TB AND DRUG-RESISTANT TB IN VULNERABLE POPULATIONS
  12. 7 COMBATING DRUG-RESISTANT TB THROUGH PUBLIC–PRIVATE COLLABORATION AND INNOVATIVE APPROACHES
  13. 8 CONFRONTING CHALLENGES TO THE SUPPLY CHAIN FOR SECOND-LINE DRUGS
  14. 9 CREATING A BLUEPRINT FOR ACTION
  15. REFERENCES
  16. APPENDIXES